|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, September 12, 2014 ) Dallas, TX -- Asthma is a disease that affects the lungs and is characterized by wheezing, coughing, breathlessness, and chest tightness. It is a chronic ailment of the respiratory tract, which is caused by the obstruction of the flow of air and bronchospasms, where the muscles around the respiratory tract swell up. The disease is believed to be caused by genetic as well as environmental factors. The American Academy of Allergy Asthma and Immunology classifies asthma under four categories: exercise-induced asthma, allergic asthma, occupational asthma, and childhood asthma. The Asthma and Allergy Foundation of America classifies asthma into two categories: allergic asthma and non-allergic asthma. It is an incurable disease but can be controlled with the help of diagnosis at the right time, followed by regular therapy.
Analysts forecast the Global Asthma Market to grow at a CAGR of 4.50 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Asthma market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various class of drugs used in the treatment of asthma:
Bronchodilators
Leukotriene antagonists
Mast cell stabilizers
Immunosuppressants
This report, the Global Asthma Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Asthma Market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=208808 .
Key Regions
Americas
APAC
EMEA
Key Vendors
AstraZeneca
F. Hoffmann-La Roche
GlaxoSmithKline
Merck
Novartis
Other Prominent Vendors
Abbott
Actavis
Amgen
AptarGroup
Astellas
Aurobindo
Biotest
Boehringer Ingelheim
Chiesi Farmaceutici
Cipla
Cytos
Dainippon Sumitomo
Dr. Reddy’s Laboratories
Glenmark
Medicinova
Mylan
Ono Pharmaceutical
Orchid Chemicals and Pharmaceuticals
Perrigo
Pfizer
Ranbaxy
Rottapharm Madaus
Skyepharma
Sosei
Sunovion
Teva
Theravance
Vectura
Market Driver
Rise in Prevalence of Disease
For a full, detailed list, view our report
Market Challenge
Unknown Etiology of Disease
For a full, detailed list, view our report
Market Trend
Popularity of Combination Therapies
For a full, detailed list, view our report
Key Questions Answered in this Report
What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Single User License is US $2500 for Discount Inquire@ http://www.rnrmarketresearch.com/contacts/discount?rname=208808 .
Abot us:Rnrmarketresearch.com is your single source for all market research needs. Our database includes 100,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
RnR Market Research
Ritesh Tiwari
+ 1 888 391 5441
sales@rnrmarketresearch.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
